Fig. 1From: Impact of co-payment level increase of antidiabetic medications on glycaemic control: an interrupted time-series study among Finnish patients with type 2 diabetesObserved time series of average glycaemic control for all patients by month. Estimated trend lines show predicted values from the segmented regression analysis for all patients and by drug groupingsBack to article page